help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cheng, J. B.
Right arrow Articles by Roberts, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cheng, J. B.
Right arrow Articles by Roberts, J. M.

Endocrinology, Vol 107, 1646-1648, Copyright © 1980 by Endocrine Society


ARTICLES

Glucocorticoids increase pulmonary beta-adrenergic receptors in fetal rabbit

JB Cheng, A Goldfien, PL Ballard and JM Roberts

beta-Adrenergic agonists stimulate surfactant release and decrease fluid in lung alveoli of fetuses. Both effects are most evident toward the end of gestation. We used [3H] dihydroalprenolol (DHA) to investigate the development of pulmonary beta-adrenergic receptors in rabbit fetuses and to study the effect of glucocorticoid treatment on the beta-receptor number. In the lung particulate preparation, DHA binding was rapid, reversible, stereoselective, and of high affinity. The order of potency for adrenergic agonists in competing for DHA binding was isoproterenol > epinephrine = norepinephrine, which is typical of interactions at a beta 1-adrenergic receptor. Using DHA, we demonstrated that the concentration of pulmonary beta-receptors increased significantly between 28 and 31 days of gestation; however, there was no change in the dissociation constant during gestation. After injecting betamethasone (0.17 mg/kg, 24 hours) into rabbits at 25 days of pregnancy, we found that the concentration of pulmonary beta- receptors increased from 44.2 +/- 6.6 fmol/mg protein in untreated fetuses to 77.9 +/- 5.6 fmol/mg protein in treated fetuses. However, this treatment did not affect the DHA binding sites in the fetal rabbit heart. Maternal treatment with the T3 analogue 3,5-dimethyl-3'- isopropyl-L-thyronine (0.5-1 mg/kg) at a dosage which increased both surfactant synthesis and release did not alter pulmonary receptor concentration. Our results indicate that the concentration of pulmonary beta-adrenergic receptors increases in the fetus at term and suggest that this increase is stimulated by endogenous glucocorticoid in fetal circulation.


This article has been cited by other articles:


Home page
ChestHome page
G. Enhorning
Surfactant in Airway Disease
Chest, April 1, 2008; 133(4): 975 - 980.
[Abstract] [Full Text] [PDF]


Home page
NeoReviewsHome page
R. D. Bland
Lung Fluid Balance During Development
NeoReviews, June 1, 2005; 6(6): e255 - e267.
[Full Text] [PDF]


Home page
ReproductionHome page
A L Fowden and A J Forhead
Endocrine mechanisms of intrauterine programming
Reproduction, May 1, 2004; 127(5): 515 - 526.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. D. Bland
Loss of liquid from the lung lumen in labor: more than a simple "squeeze"
Am J Physiol Lung Cell Mol Physiol, April 1, 2001; 280(4): L602 - L605.
[Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
L. E. Cornett, F. C. Hiller, S. E. Jacobi, W. Cao, and D. W. McGraw
Identification of a Glucocorticoid Response Element in the Rat beta 2-Adrenergic Receptor Gene
Mol. Pharmacol., December 1, 1998; 54(6): 1016 - 1023.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Cell Physiol.Home page
X. Jiang, D. H. Ingbar, and S. M. O'Grady
Adrenergic stimulation of Na+ transport across alveolar epithelial cells involves activation of apical Cl- channels
Am J Physiol Cell Physiol, December 1, 1998; 275(6): C1610 - C1620.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
K. Demissie, S. W. Marcella, M. B. Breckenridge, and G. G. Rhoads
Maternal Asthma and Transient Tachypnea of the Newborn
Pediatrics, July 1, 1998; 102(1): 84 - 90.
[Abstract] [Full Text]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
D. Bourchier and P. J Weston
Randomised trial of dopamine compared with hydrocortisone for the treatment of hypotensive very low birthweight infants
Arch. Dis. Child. Fetal Neonatal Ed., May 1, 1997; 76(3): 174F - 178.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
J. B. Cheng, J. W. Watson, C. J. Pazoles, J. D. Eskra, R. J. Griffiths, V. L. Cohan, C. R. Turner, H. J. Showell, and E. R. Pettipher
The Phosphodiesterase Type 4 (PDE4) Inhibitor CP-80,633 Elevates Plasma Cyclic AMP Levels and Decreases Tumor Necrosis Factor-alpha (TNFalpha ) Production in Mice: Effect of Adrenalectomy
J. Pharmacol. Exp. Ther., February 1, 1997; 280(2): 621 - 626.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1980 by The Endocrine Society